United Kingdom

Fujifilm in Europe, the Middle East and Africa

Fujifilm in EMEA is building toward the future with innovations spanning a growing spectrum of technologies.

Fujifilm first penetrated into overseas markets primarily through its Imaging Solutions business. The company established a German subsidiary in charge of the comprehensive management of its European operations in 1966 and a manufacturing company in the Netherlands which was tasked with manufacturing color paper and color films in 1982.

Today, FUJIFILM Europe GmbH (Duesseldorf, Germany) acts as Strategic Headquarters for the region and supports its group companies in Europe by formulating marketing and corporate strategies. In addition, FUJIFILM Europe B.V. (Tilburg, The Netherlands) covers the logistics, finance and procurement control functions for the entire European market.

Fujifilm operates seven major manufacturing sites in Europe, producing CTP plates, color paper, chemicals, inks, colorants for inkjets printers, toners, electronic materials for semiconductor production, biopharmaceuticals and others.

Nowadays Fujifilm entities operate in 55 group companies in Europe and beyond. More than 4.000 people are engaged in R&D, manufacturing, marketing&sales and service support. Throughout EMEA region they serve a range of industries including medical, life science, graphic arts, electronic materials, chemical, optics, recording media and photographic technologies.

Fujifilm Europe HQ

Anschrift und Kontakt

Facts and figures

Facts and figures

We have leveraged our imaging and information technology to become a global player known for innovation in a wide range of industries. Nowadays, our entities operate in 46 group companies in Europe and beyond. More than 4,500 people are engaged in a strong sales and support network of our seven business domains throughout the EMEA region.

Dedication to Innovation

The Fujifilm story in Europe is one of lasting growth and transformation, and our company exists today as a successful diversified international corporation with a leading position in many business fields. Fujifilm first made a name for itself as a photographic film manufacturer, setting up a European HQ in Düsseldorf, Germany in 1966. Fujifilm signature green photo film boxes were in stores everywhere, and as production boomed manufacturing was brought to Tilburg, Netherlands, which continues to be the main FUJIFILM Europe manufacturing and logistics hub, and home of R&D and open innovation. Fujifilm consistently evolved over the last century, establishing itself as a market leader in Europe in the business fields of Photo Imaging and Printing, Graphic Systems, Electronic Imaging and Optical Devices, Medical Systems, Industrial Products and Recording Media. Embracing the challenge of a sharp decline in photographic film demand, Fujifilm moved into the new century seeking innovative ways of applying its fundamental proprietary technologies and expertise, and over the last decade the company has taken major steps to transform itself with a particular focus on healthcare. Building upon a history of over 80 years as a medical imaging specialist, Fujifilm now covers the entire patient care pathway from prevention, to diagnosis and treatment, with pharmaceuticals research and development, biopharmaceutical manufacturing and regenerative medicine now part of the unique Fujifilm portfolio. Our innovations over the decades find the company today with both highly specialized healthcare expertise and technologies. Collagen, a core component of photographic film, plays an important role in regenerative medicine and provide Fujifilm the ability to manipulate functional molecules and polymer at its European Research Laboratory which today is fuelling the race to cure cellular-based diseases. Maximising an extraordinary background of innovation, FUJIFILM Europe is also focused on researching developing, manufacturing and delivering a new generation of pharmaceutical products. FUJIFILM Diosynth Biotechnologies, operating in Europe from Billingham, U.K., are a world leader in the development and production of market-leading biological drugs, vaccines, active pharmaceutical ingredients and advanced therapies. The potential of Fujifilm’s own pharmaceutical pipeline is also set to be realised Europe in the near future, with novel drugs with unique mechanisms of action set to take the fight to cancer, Alzheimer’s disease and tackle many more unmet medical needs. As our business continues to change and evolve in every sector we operate, FUJIFILM Europe is well positioned for the future and will continue to provide top-quality products and services that contribute to the advancement of culture, science, technology, industry, the environment and society.


In 2014, Fujifilm established “Value from Innovation” as our corporate slogan, declaring our company‘s commitment to continue producing innovative new technologies, products and services. In line with the slogan, in 2018 we launched a new global branding campaign entitled NEVER STOP highlighting Fujifilm‘s commitment to providing new value through innovative advanced technologies, contributing to the solution of various issues facing society, while also declaring a commitment to NEVER STOP producing value through innova tion, a strong statement of Fujifilm‘s ambition and approach which this campaign will communicate to people around the world. Our message is clear. For more than 80 years, we‘ve continued to transform ourselves. Building from our origins as a photographic film company known for innovations like the world‘s first high-speed ISO 400 film, we evolved into a technology company working in areas such as healthcare, highly-functional materials, imaging solutions, document solutions and more.



In healthcare, FUJIFILM is engaged in prevention, diagnosis and treatment. We are pioneering the world of biopharmaceuticals and regenerative medicine, while also developing revolutionary healthcare IT, allowing medical professionals to make more precise diagnoses more quickly. We are transforming the world of display technology by advancing touch-panel sensor films and organic electroluminescent displays, and are also adapting our film technology to create membranes and filters that are, among other things, used to help brewers stabilise the quality of their products. By leveraging our advanced and unique technologies, we will continue creating value from innovation and contribute to solving social challenges. Which means we‘ll never stop building on our experience and expertise to help transform ourselves, and the world.